M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice

A. Fisher, R. Brandeis, S. Chapman, Z. Pittel, D. M. Michaelson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry